That was when it last traded in the $3.75 - $4.00 range.
Hope it reaches and surpasses this price in the next few days. The FDA news regarding the full response from PIP about Sparvax is due any day now.
Any news on Sparvax should move the price significantly. Soon to be a two-drug company with a market value significantly less than $400 million. Not many biotech companies with two potential drug candidates are priced so cheaply.